Status:
COMPLETED
Multiple Sclerosis, Menstrual Cycle and Physical Acivity
Lead Sponsor:
Universidad de Almeria
Conditions:
Multiple Sclerosis
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
This study aims to identify moderating variables that modify satisfaction with physical activity practice throughout the menstrual cycle (MC) in women with and without multiple sclerosis (MS) during H...
Eligibility Criteria
Inclusion
- women aged between 18-40 years;
- women with a menstrual cycle length of ≥ 21 days and ≤ 35 days of natural menstruation;
- absence of iron deficiency anaemia (serum ferritin \> 20 μg/L, hemoglobin \> 115 μg/L, transferrin saturation \> 16%)
- being in a stable phase of the disease,
- to ambulate autonomously for more than 100 meters
Exclusion
- a score \< 2 or \> 6 on the Expanded Disability Status Scale (EDSS);
- experienced a relapse in the 12 months prior to enrolment;
- received corticosteroid treatment in the previous 2 months;
- participated in a structured exercise programme in the past 6 months;
- secondary amenorrhoea (absence of ≥ 3 consecutive periods despite not being pregnant and having previous menstruation);
- used or currently use hormonal contraceptives for 3 months before recruitment
- reported musculoskeletal or neurological injuries not associated with MS, recent surgical interventions, or pregnancies in the previous year,
- have unrelated diseases to MS
Key Trial Info
Start Date :
May 6 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06105463
Start Date
May 6 2024
End Date
December 30 2024
Last Update
February 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Almeria
Almería, Almeria, Spain, 04120